Harvard Business Review

JANUARY 6, 2025

AI is merely one facet of a sweeping technological change underway, and companies that fail to recognize the importance of other converging technologies risk being left behind. Two other technologies advanced sensors and biotechnology are less visible, though no less important, and have been quietly advancing.

Biotechnology 28

Biotechnology Technology Industry Innovation 28

Skip Prichard

JULY 22, 2019

Innovation Capital. Whether you have invented an amazing new technology or product, you could still fail. And one of the most overlooked reasons for entrepreneurial failure is innovation capital. He offers a unique perspective on innovation and winning in the marketplace. The Components of Innovation Capital.

Innovation 83

Innovation Reputation Social Capital How To 83

Strategy Driven

NOVEMBER 18, 2019

There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. Technology. Technology is innovation and looks likely to form the foundation for much of our society for the foreseeable future. Financial sector.

Health Care 66

Health Care Biotechnology Energy Insurance 66

Strategy Driven

MAY 12, 2021

Leapfrogging advances in materials, photonics, optics, and electronics have precipitated a rising demand for 3D display technologies. The increased demand for enhanced imaging and the adoption of 3D technologies in smartphones, HMD devices, projector devices, and monitors are expected to catapult 3D displays across a new threshold of realism.

Technology 98

Technology Content Video Globalization 98

Innovation Excellence

JANUARY 20, 2025

GUEST POST from Greg Satell Many experts suspect that the COVID crisis is receding into the background. It is, of course, hard to know for sure. There will continue to be debate and we will still need to have some mitigating measures in place. Still, for the most part, people are back at work, kids […]

Crisis 118

Crisis Course Biotechnology Technology 118

Harvard Business Review

APRIL 27, 2012

It's an age of unprecedented, staggering technological change. But he's not alone in the judgment that we're not actually living in an era of great innovation. but the emerging markets boom has generally been more about catching up than exploiting cutting-edge technology.). Or something like that.

Stephenson 20

Stephenson Innovation Biotechnology eBook 20

Harvard Business Review

MARCH 28, 2012

This ongoing struggle raises an issue that is endemic in such acquisitions: In search of innovation, big companies often buy other companies whose most innovative days are almost at an end. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now.

Innovation 14

Innovation Company Biotechnology CFO 14

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 14

Innovation Short-term Telecommunications Long-term 14

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 11

Globalization Innovation Decentralization Chemicals 11

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And biotechnology and medical devices are among the leading areas for venture capital funding. The first lays the blame at the door of the government.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MARCH 11, 2014

That is, why bother trying to innovate if no matter what they do, large companies can no longer maintain a sustainable advantage and their life spans are just getting shorter and shorter? In these markets if existing companies don’t rise to the innovation challenge, no one will. “Why bother?”.

Venture Capitalist 10

Venture Capitalist Innovation Company Supply Chain 10

Harvard Business Review

MAY 2, 2011

Without operating in the former, they won't be able to attain economies of scale; sans the latter, they're unlikely to continue developing state-of-the-art technologies. Moreover, it forgot that it will continue to do well in China and India not just by keeping costs low but also by developing new technologies.

Globalization 15

Globalization Marketing Venture Capitalist Biotechnology 15

Harvard Business Review

OCTOBER 26, 2011

Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail).

Energy 13

Energy Finance IPO Biotechnology 13

Harvard Business Review

JUNE 16, 2016

Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. At the same time, the marketplace has become so fiercely competitive—and investors so demanding—that few are willing to take a flyer on an unproven technology.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

JUNE 12, 2012

Paul Kennedy's seminal Rise and Fall of the Great Powers captures the way technological and economic advances have converted into strategic advantage, and how failure to "lock in" that edge accelerates imperial decline. Technik , then, is the technological quotient of civilization. It pledges $1.5 The contrast between the U.N.'s

First-mover Advantage 10

First-mover Advantage GDP Technology Biotechnology 10

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 11

Skills Power Six Sigma Disruptive Innovation 11

Harvard Business Review

OCTOBER 16, 2013

If we want to have a strong economy, we need to make sure we’re tilting the playing field in favor of entrepreneurs that are trying to challenge the status quo, innovate, create new products and services, disrupt existing industry, usher in a new way. They are fueling innovation and growth. A restaurant might start.

Venture Capitalist 14

Venture Capitalist Company Biotechnology Transportation 14

Harvard Business Review

MARCH 8, 2013

Many of the revolutionary technologies that make the iPhone and other products and services "smart" were funded by the U.S. This also stands in stark contrast to the steps that Apple, Google, and other technology companies take to avoid paying taxes. government's risky investments have had for technology-based corporations.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Technology 8

Harvard Business Review

MARCH 5, 2012

Sure, with improvements in information technology and communication, some services are becoming more tradable and that creates opportunities for the U.S. This tight connection between R&D, innovation, and production is present in sectors like biotechnology, advanced materials, and nanotechnology. But let's not kid ourselves.

Health Care 10

Health Care Biotechnology Industry Policies 10

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., And what did they say was their biggest concern? Not competitive threats. Not rising costs.

Talent Management 10

Talent Management Company Telecommunications Management 10

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. vincent tsui FOR HBR. Since World War II, the U.S. Google got its start from a federal grant.

Company 8

Company Innovation Competitive Advantage White Paper 8

Harvard Business Review

OCTOBER 23, 2014

It’s only recently, though, that advances in information technology have made it possible for predictive tools to access and manipulate big data, and to do so continuously — accelerating the generation of insights, and opening up opportunities to anticipate issues with unprecedented precision. Health Information & technology'

Health Care 9

Health Care Pharmaceuticals Information Technology Supply Chain 9

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. Innovating for Value in Health Care. Insight Center. Sponsored by Medtronic.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

JUNE 4, 2018

’s “once unchallenged preeminence in commerce, industry, science, and technological innovation is being overtaken by competitors throughout the world.” .” This groundbreaking report, commissioned by President Ronald Reagan, concluded that the U.S.’s

Education 8

Education Company Biotechnology Human Capital 8

The Horizons Tracker

FEBRUARY 6, 2025

Market opportunities, timing, and strong entrepreneurial foundations are key to building successful “university innovation entrepreneurial ecosystems” (UIEEs) like Silicon Valley, according to research from the Keck Graduate Institute. “The key is having a commercial opportunity that technology can solve.

Venture Capitalist 71

Venture Capitalist Biotechnology How To Entrepreneur 71

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. and technological uncertainty (can we make a desirable solution?) Technological uncertainty results from unknowns regarding the technologies that might emerge or be combined to create a new solution.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

NOVEMBER 9, 2016

To cope with the cyclical variations of copper prices, the industry made an innovative leap into the health care sector, a move that represents a clear departure from the commodity trap. But the regional steel industry’s leaders minimized exposure to price volatility by focusing on product and process innovations.

Cooper 15

Cooper Long-term Industry Health Care 15